In this study, we demonstrated that higher IDO1 expression at the tumour invasion front correlates with progressive disease and impaired clinical outcome in a specific subset of patients with CRC, suggesting that IDO1 is an independent and reliable prognostic indicator for CRC. This evidence concerns the gene IDO1 and neoplasm.